Instructions for storing Seladelpar medicine

Seladelpar (Seladelpar) capsules are 10 mg in size. The main body of the capsule is light gray and opaque, and the cap is dark blue and opaque. This color design not only facilitates identification, but also prevents the impact of light on the drug ingredients to a certain extent. According to overseas instructions, the recommended storage temperature of Seladelpar is 20°C to 25°C (68°F to 77°F), with slight deviations allowed in the range of 15°C to 30°C (59°F to 86°F). This storage temperature range is designed to ensure the chemical stability and durability of the drug's efficacy and avoid degradation of the active ingredient or damage to the capsule due to high temperatures, low temperatures, moisture or light.

Storage of drugs outside the specified temperature conditions may cause changes in the appearance of the capsules, such as discoloration, adhesion or cracking, and may also reduce efficacy and affect clinical treatment effects. In actual use, patients should keepSeladelpar capsules in a dry, cool and dark environment, and keep them out of the reach of children. Medications should be kept in their original packaging and not opened until just before use to minimize the effects of air, humidity and light on the active ingredients. Especially in humid or high-temperature environments, such as summer or tropical areas, patients should be careful not to place the capsules in the bathroom, window sill or in direct sunlight to prevent the capsules from getting damp or deformed, resulting in reduced efficacy.

Seladelpar is an important drug in the treatment of primary biliary cholangitis (PBC). Its chemical components are sensitive to temperature, humidity and light. Standardized storage can not only maintain the activity of the drug, but also ensure that patients can obtain stable therapeutic effects during long-term medication. Overseas clinical experience shows that good storage habits can effectively reduce patients’ dose fluctuations or unstable efficacy during long-term medication. Especially for patients with chronic cholestatic diseases who require continuous medication for months or even years, drug stability directly affects the treatment effect and quality of life.

Reference materials:https://go.drugbank.com/drugs/DB12390